T Quattrin

Summary

Affiliation: State University of New York at Buffalo
Country: USA

Publications

  1. pmc Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study
    Lucy Mastrandrea
    Department of Pediatrics, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA
    Diabetes Care 32:1244-9. 2009
  2. ncbi request reprint Efficacy of family-based weight control program for preschool children in primary care
    Teresa Quattrin
    Pediatric University at Buffalo, Buffalo, New York, USA
    Pediatrics 130:660-6. 2012
  3. pmc Development and validation of the WEll-being and Satisfaction of CAREgivers of Children with Diabetes Questionnaire (WE-CARE)
    Joseph C Cappelleri
    Pfizer Global Research and Development, Groton, CT, USA
    Health Qual Life Outcomes 6:3. 2008
  4. ncbi request reprint Inhaled insulin: a novel and non-invasive way for insulin administration?
    Teresa Quattrin
    Division of Endocrinology Diabetes, Women and Children s Hospital of Buffalo, Associate Professor of Pediatrics, State University of New York at Buffalo, 219 Bryant Street, Buffalo, New York 14222, USA
    Curr Drug Saf 1:151-8. 2006
  5. ncbi request reprint Obese children who are referred to the pediatric endocrinologist: characteristics and outcome
    Teresa Quattrin
    Division of Endocrinology Diabetes, Women s and Children s Hospital of Buffalo, 219 Bryant St, Buffalo, NY 14222, USA
    Pediatrics 115:348-51. 2005
  6. ncbi request reprint Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes
    Teresa Quattrin
    State University of New York at Buffalo, Division of Endocrinology, The Women and Children s Hospital of Buffalo, Kaleida Health, 219 Bryant St, Buffalo, NY 14222, USA
    Expert Opin Pharmacother 5:2597-604. 2004
  7. ncbi request reprint Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial
    Teresa Quattrin
    The Women and Children s Hospital of Buffalo, School of Medicine and Biochemical Sciences, State University of New York at Buffalo, Buffalo, New York 14222, USA
    Diabetes Care 27:2622-7. 2004
  8. ncbi request reprint Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group
    T Quattrin
    Department of Pediatrics, Children s Hospital of Buffalo, State University of New York at Buffalo, 14222, USA
    J Pediatr Endocrinol Metab 14:267-77. 2001
  9. ncbi request reprint Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile
    T Quattrin
    Department of Pediatrics, Children s Hospital of Buffalo, New York, USA
    Diabetes Care 20:374-80. 1997
  10. ncbi request reprint Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system
    K Thrailkill
    Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Clin Endocrinol Metab 82:1181-7. 1997

Collaborators

Detail Information

Publications17

  1. pmc Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study
    Lucy Mastrandrea
    Department of Pediatrics, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York, USA
    Diabetes Care 32:1244-9. 2009
    ..To gather preliminary data on the feasibility and efficacy of etanercept therapy to prolong endogenous insulin production in pediatric patients with newly diagnosed type 1 diabetes...
  2. ncbi request reprint Efficacy of family-based weight control program for preschool children in primary care
    Teresa Quattrin
    Pediatric University at Buffalo, Buffalo, New York, USA
    Pediatrics 130:660-6. 2012
    ..To test the efficacy of an innovative family-based intervention for overweight preschool-aged children and overweight parents conducted in the primary care setting...
  3. pmc Development and validation of the WEll-being and Satisfaction of CAREgivers of Children with Diabetes Questionnaire (WE-CARE)
    Joseph C Cappelleri
    Pfizer Global Research and Development, Groton, CT, USA
    Health Qual Life Outcomes 6:3. 2008
    ....
  4. ncbi request reprint Inhaled insulin: a novel and non-invasive way for insulin administration?
    Teresa Quattrin
    Division of Endocrinology Diabetes, Women and Children s Hospital of Buffalo, Associate Professor of Pediatrics, State University of New York at Buffalo, 219 Bryant Street, Buffalo, New York 14222, USA
    Curr Drug Saf 1:151-8. 2006
    ..In these patients, who had received inhaled insulin for at least 4 years, annualized changes of FEV1 and DLCO were similar in the group treated with inhaled insulin compared to the group treated with sub-cutaneous insulin...
  5. ncbi request reprint Obese children who are referred to the pediatric endocrinologist: characteristics and outcome
    Teresa Quattrin
    Division of Endocrinology Diabetes, Women s and Children s Hospital of Buffalo, 219 Bryant St, Buffalo, NY 14222, USA
    Pediatrics 115:348-51. 2005
    ..The objective of this study was to characterize a population of obese children who were referred to a pediatric endocrinology clinic and to analyze the outcome of the referral...
  6. ncbi request reprint Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes
    Teresa Quattrin
    State University of New York at Buffalo, Division of Endocrinology, The Women and Children s Hospital of Buffalo, Kaleida Health, 219 Bryant St, Buffalo, NY 14222, USA
    Expert Opin Pharmacother 5:2597-604. 2004
    ..Further studies are needed to clarify the significance of this finding. Inhaled insulin appears to be a non-invasive, well-tolerated and -liked modality of treatment, with potential in both Type 1 and 2 diabetes...
  7. ncbi request reprint Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial
    Teresa Quattrin
    The Women and Children s Hospital of Buffalo, School of Medicine and Biochemical Sciences, State University of New York at Buffalo, Buffalo, New York 14222, USA
    Diabetes Care 27:2622-7. 2004
    ..The aim of this study was to determine whether premeal pulmonary delivery of rapid-acting, dry-powder insulin (Exubera) plus Ultralente could provide glycemic control comparable to a conventional insulin regimen in type 1 diabetes...
  8. ncbi request reprint Improvement of HbA1c without increased hypoglycemia in adolescents and young adults with type 1 diabetes mellitus treated with recombinant human insulin-like growth factor-I and insulin. rhIGF-I in IDDM Study Group
    T Quattrin
    Department of Pediatrics, Children s Hospital of Buffalo, State University of New York at Buffalo, 14222, USA
    J Pediatr Endocrinol Metab 14:267-77. 2001
    ..We present the efficacy and safety data pertinent to the younger subset of participants (11-21 years)...
  9. ncbi request reprint Dual hormonal replacement with insulin and recombinant human insulin-like growth factor I in IDDM. Effects on glycemic control, IGF-I levels, and safety profile
    T Quattrin
    Department of Pediatrics, Children s Hospital of Buffalo, New York, USA
    Diabetes Care 20:374-80. 1997
    ..To examine if dual replacement with insulin and rhIGF-I, recombinant human insulin-like growth factor I (rhIGF-I) may be safe and result in improved metabolic control and reduced insulin usage...
  10. ncbi request reprint Dual hormonal replacement therapy with insulin and recombinant human insulin-like growth factor (IGF)-I in insulin-dependent diabetes mellitus: effects on the growth hormone/IGF/IGF-binding protein system
    K Thrailkill
    Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Clin Endocrinol Metab 82:1181-7. 1997
    ....
  11. ncbi request reprint Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group
    K M Thrailkill
    Department of Pediatrics, University of Kentucky, Lexington, USA
    Diabetes Care 22:585-92. 1999
    ..To study the effects of 12 weeks of cotherapy with recombinant human IGF-I (rhIGF-I) and insulin on glycemic control in patients with type 1 diabetes...
  12. ncbi request reprint Efficacy and safety of inhaled human insulin (Exubera) compared to subcutaneous insulin in children ages 6 to 11 years with type 1 diabetes mellitus: results of a 3-month, randomized, parallel trial
    Neil H White
    Department of Pediatrics, Washington University School of Medicine, St Louis, MO 63110, USA
    J Pediatr Endocrinol Metab 21:555-68. 2008
    ..To compare the efficacy and safety of Exubera (EXU) with subcutaneous (SC) insulin in children, ages 6-11 years, with type 1 diabetes mellitus...
  13. ncbi request reprint Clinical evaluation of inhaled insulin
    Lucy D Mastrandrea
    Division of Endocrinology Diabetes, Department of Pediatrics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, The Women s and Children s Hospital, 219 Bryant Street, Buffalo, New York 14222, USA
    Adv Drug Deliv Rev 58:1061-75. 2006
    ..In addition, the efficacy of inhaled insulin in both type 1 and type 2 diabetic populations will be discussed. Finally, the available safety data with respect to the unique pulmonary effects of inhaled insulin will be covered...
  14. pmc Young women with type 1 diabetes have lower bone mineral density that persists over time
    Lucy D Mastrandrea
    Department of Pediatrics, University at Buffalo, School of Medicine and Biomedical Sciences, Buffalo, New York, USA
    Diabetes Care 31:1729-35. 2008
    ..We here report 2-year follow-up BMD data in this cohort to determine the natural history of BMD in young women with and without diabetes...
  15. ncbi request reprint Detecting overweight children in primary care: do national data reflect the typical urban practice?
    Elena Sutu
    Division of Endocrinology Diabetes, Women and Children s Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222, USA
    J Fam Pract 55:976-80. 2006
    ..Children seen for a sick-child visit may be at higher risk for overweight; thus, we recommend that height and weight measurements be obtained during these visits...
  16. ncbi request reprint Does low bone mineral density start in post-teenage years in women with type 1 diabetes?
    Emily Y Liu
    The Women and Children s Hospital of Buffalo, Division of Endocrinology Diabetes, Buffalo, New York 14222, USA
    Diabetes Care 26:2365-9. 2003
    ....
  17. ncbi request reprint Fasting glucose is a risk factor for breast cancer: a prospective study
    Paola Muti
    Department of Social and Preventive Medicine, University at Buffalo, State University of New York, Buffalo 14214, USA
    Cancer Epidemiol Biomarkers Prev 11:1361-8. 2002
    ..These results indicate that chronic alteration of glucose metabolism is related to breast cancer development...

Research Grants3

  1. Treating Overweight Youth: A Family Based Approach in Primary Care
    Teresa Quattrin; Fiscal Year: 2009
    ..This study is an important step towards providing pediatricians with effective tools to treat overweight in primary care. ..
  2. Treating Overweight Youth: A Family Based Approach in Primary Care
    Teresa Quattrin; Fiscal Year: 2010
    ..This study is an important step towards providing pediatricians with effective tools to treat overweight in primary care. ..